These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10077511)

  • 1. Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty.
    Manegold C; Alwazzeh M; Jablonowski H; Adams O; Medve M; Seidlitz B; Heidland U; Häussinger D; Strauer BE; Heintzen MP
    Circulation; 1999 Mar; 99(10):1290-4. PubMed ID: 10077511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy.
    Zhou YF; Leon MB; Waclawiw MA; Popma JJ; Yu ZX; Finkel T; Epstein SE
    N Engl J Med; 1996 Aug; 335(9):624-30. PubMed ID: 8687516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis.
    Blum A; Giladi M; Weinberg M; Kaplan G; Pasternack H; Laniado S; Miller H
    Am J Cardiol; 1998 Apr; 81(7):866-8. PubMed ID: 9555776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus infection and coronary restenosis.
    Bertrand ME; Bauters C
    Circulation; 1999 Mar; 99(10):1278-9. PubMed ID: 10077508
    [No Abstract]   [Full Text] [Related]  

  • 5. Prior cytomegalovirus infection does not predict clinical outcome after percutaneous transluminal coronary angioplasty.
    Tiran A; Tio RA; Oostenveld E; Harmsen MC; Tiran B; den Heijer P; Monnink SH; Wilders-Truschnig MM; The TH
    Cardiology; 1998; 90(4):263-8. PubMed ID: 10085487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty.
    Carlsson J; Miketic S; Brom J; Ross R; Bachmann H; Tebbe U
    Int J Cardiol; 2000 Apr; 73(2):165-71. PubMed ID: 10817856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response to human cytomegalovirus in patients undergoing percutaneous transluminal coronary angioplasty.
    Tiran A; Tio RA; Oostenveld E; Harmsen MC; Tiran B; Den Heijer P; Monnink SH; Wilders-Truschnig MM; The TH
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):45-9. PubMed ID: 9874662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of percutaneous transluminal coronary angioplasty in heart transplant recipients.
    Schnetzler B; Drobinski G; Dorent R; Camproux AC; Ghossoub J; Thomas D; Gandjbakhch I
    J Heart Lung Transplant; 2000 Jun; 19(6):557-65. PubMed ID: 10867336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia pneumoniae seropositivity predicts the risk of restenosis after percutaneous transluminal coronary angioplasty.
    Hayashida K; Tanaka M; Morita H; Hayashi F; Inada T; Suzuki H; Sakamoto T; Katsuragawa M; Hibino H; Kambara H
    Heart Vessels; 2002 May; 16(4):137-45. PubMed ID: 12224784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Previous cytomegalovirus infection and restenosis after aggressive angioplasty with provisional stenting.
    Mueller C; Hodgson JM; Bestehorn HP; Brutsche M; Perruchoud AP; Marsch S; Roskamm H; Buettner HJ
    J Interv Cardiol; 2003 Aug; 16(4):307-13. PubMed ID: 14562670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST).
    vom Dahl J; Dietz U; Haager PK; Silber S; Niccoli L; Buettner HJ; Schiele F; Thomas M; Commeau P; Ramsdale DR; Garcia E; Hamm CW; Hoffmann R; Reineke T; Klues HG
    Circulation; 2002 Feb; 105(5):583-8. PubMed ID: 11827923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed angiographic analysis of high-speed mechanical rotational atherectomy in human coronary arteries.
    Safian RD; Niazi KA; Strzelecki M; Lichtenberg A; May MA; Juran N; Freed M; Ramos R; Gangadharan V; Grines CL
    Circulation; 1993 Sep; 88(3):961-8. PubMed ID: 8353923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study.
    Schiele F; Batur MK; Seronde MF; Meneveau N; Sewoke P; Bassignot A; Couetdic G; Caulfield F; Bassand JP
    Heart; 2001 Mar; 85(3):304-11. PubMed ID: 11179272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease?
    Eryol NK; Kiliç H; Gül A; Ozdogru I; Inanç T; Dogan A; Topsakal R; Basar E
    Int Heart J; 2005 Mar; 46(2):205-9. PubMed ID: 15876804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial.
    Mauri L; Bonan R; Weiner BH; Legrand V; Bassand JP; Popma JJ; Niemyski P; Prpic R; Ho KK; Chauhan MS; Cutlip DE; Bertrand OF; Kuntz RE
    Am J Cardiol; 2002 Nov; 90(10):1079-83. PubMed ID: 12423707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis.
    Dauerman HL; Baim DS; Cutlip DE; Sparano AM; Gibson CM; Kuntz RE; Carrozza JP; Garber GR; Cohen DJ
    Am J Cardiol; 1998 Aug; 82(3):277-84. PubMed ID: 9708653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.